Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Combination therapies might work better for some vitiligo patients, but results vary.

Minoxidil and finasteride are key treatments for hair loss.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

Skin issues can indicate immune system problems.

Two Hispanic women developed Plica neuropathica, a condition causing tangled hair, possibly due to hair damage and various risk factors.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

A 7-year-old dog with a rare autoimmune disease was euthanized due to severe anemia and poor prognosis.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The virus linked to a rare disease was found in a patient's blood and urine before skin symptoms appeared.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.